Annual Long Term Liabilities:
$758.79M-$188.63M(-19.91%)Summary
- As of today, JAZZ annual total long term liabilities is $758.79 million, with the most recent change of -$188.63 million (-19.91%) on December 31, 2024.
- During the last 3 years, JAZZ annual long term liabilities has fallen by -$652.94 million (-46.25%).
- JAZZ annual long term liabilities is now -46.25% below its all-time high of $1.41 billion, reached on December 31, 2021.
Performance
JAZZ Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Long Term Liabilities:
$775.85M+$13.93M(+1.83%)Summary
- As of today, JAZZ quarterly total long term liabilities is $775.85 million, with the most recent change of +$13.93 million (+1.83%) on June 30, 2025.
- Over the past year, JAZZ quarterly long term liabilities has dropped by -$98.79 million (-11.29%).
- JAZZ quarterly long term liabilities is now -49.91% below its all-time high of $1.55 billion, reached on June 30, 2021.
Performance
JAZZ Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
JAZZ Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -19.9% | -11.3% |
| 3Y3 Years | -46.3% | -36.7% |
| 5Y5 Years | +124.3% | +157.9% |
JAZZ Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -46.3% | at low | -26.6% | +2.3% |
| 5Y | 5-Year | -46.3% | +224.5% | -49.9% | +256.5% |
| All-Time | All-Time | -46.3% | +9486.7% | -49.9% | +9702.3% |
JAZZ Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $775.85M(+1.8%) |
| Mar 2025 | - | $761.92M(+0.4%) |
| Dec 2024 | $758.79M(-19.9%) | $758.79M(-15.9%) |
| Sep 2024 | - | $902.75M(+3.2%) |
| Jun 2024 | - | $874.64M(-3.6%) |
| Mar 2024 | - | $907.14M(-4.3%) |
| Dec 2023 | $947.42M(-9.4%) | $947.42M(-2.2%) |
| Sep 2023 | - | $968.71M(-6.6%) |
| Jun 2023 | - | $1.04B(-0.4%) |
| Mar 2023 | - | $1.04B(-0.4%) |
| Dec 2022 | $1.05B(-25.9%) | $1.05B(-1.1%) |
| Sep 2022 | - | $1.06B(-13.7%) |
| Jun 2022 | - | $1.23B(-9.0%) |
| Mar 2022 | - | $1.35B(-4.6%) |
| Dec 2021 | $1.41B(+503.7%) | $1.41B(-3.4%) |
| Sep 2021 | - | $1.46B(-5.6%) |
| Jun 2021 | - | $1.55B(+611.8%) |
| Mar 2021 | - | $217.63M(-6.9%) |
| Dec 2020 | $233.86M(-30.9%) | $233.86M(-18.5%) |
| Sep 2020 | - | $287.01M(-4.6%) |
| Jun 2020 | - | $300.80M(+5.0%) |
| Mar 2020 | - | $286.58M(-15.3%) |
| Dec 2019 | $338.33M(-37.1%) | $338.33M(-5.7%) |
| Sep 2019 | - | $358.79M(-12.8%) |
| Jun 2019 | - | $411.60M(-1.2%) |
| Mar 2019 | - | $416.45M(-22.5%) |
| Dec 2018 | $537.56M(-6.7%) | $537.56M(-3.4%) |
| Sep 2018 | - | $556.60M(-2.9%) |
| Jun 2018 | - | $572.95M(-2.5%) |
| Mar 2018 | - | $587.89M(+2.0%) |
| Dec 2017 | $576.20M(-14.3%) | $576.20M(-19.7%) |
| Sep 2017 | - | $717.73M(+0.1%) |
| Jun 2017 | - | $716.80M(+2.5%) |
| Mar 2017 | - | $699.47M(+4.1%) |
| Dec 2016 | $671.95M(+88.5%) | $671.95M(-19.5%) |
| Sep 2016 | - | $834.34M(+115.4%) |
| Jun 2016 | - | $387.26M(+1.3%) |
| Mar 2016 | - | $382.27M(+7.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $356.47M(-14.7%) | $356.47M(-8.3%) |
| Sep 2015 | - | $388.53M(+1.4%) |
| Jun 2015 | - | $383.30M(+1.7%) |
| Mar 2015 | - | $377.02M(-9.8%) |
| Dec 2014 | $417.95M(+115.2%) | $417.95M(-7.5%) |
| Sep 2014 | - | $451.84M(-8.0%) |
| Jun 2014 | - | $490.93M(-2.4%) |
| Mar 2014 | - | $502.82M(+158.8%) |
| Dec 2013 | $194.25M(-14.3%) | $194.25M(+0.7%) |
| Sep 2013 | - | $192.88M(+2.9%) |
| Jun 2013 | - | $187.36M(+1.0%) |
| Mar 2013 | - | $185.56M(-18.1%) |
| Dec 2012 | $226.59M(+2762.8%) | $226.59M(+0.1%) |
| Sep 2012 | - | $226.41M(-1.6%) |
| Jun 2012 | - | $229.98M(+2471.3%) |
| Mar 2012 | - | $8.94M(+13.0%) |
| Dec 2011 | $7.92M(-82.5%) | $7.92M(-11.6%) |
| Sep 2011 | - | $8.95M(-14.7%) |
| Jun 2011 | - | $10.50M(-67.9%) |
| Mar 2011 | - | $32.66M(-27.8%) |
| Dec 2010 | $45.24M(-62.6%) | $45.24M(-10.8%) |
| Sep 2010 | - | $50.70M(-11.5%) |
| Jun 2010 | - | $57.28M(-45.9%) |
| Mar 2010 | - | $105.79M(-12.6%) |
| Dec 2009 | $120.98M(+228.0%) | $120.98M(-17.4%) |
| Sep 2009 | - | $146.50M(+351.9%) |
| Jun 2009 | - | $32.42M(-3.8%) |
| Mar 2009 | - | $33.70M(-8.6%) |
| Dec 2008 | $36.88M(-68.1%) | $36.88M(-75.7%) |
| Sep 2008 | - | $151.53M(-0.2%) |
| Jun 2008 | - | $151.91M(+0.0%) |
| Mar 2008 | - | $151.85M(+31.2%) |
| Dec 2007 | $115.71M(-67.9%) | $115.71M(-0.0%) |
| Sep 2007 | - | $115.72M(-0.4%) |
| Jun 2007 | - | $116.17M(+14.9%) |
| Mar 2007 | - | $101.09M(-71.9%) |
| Dec 2006 | $360.35M(+38.8%) | $360.35M(+38.8%) |
| Dec 2005 | $259.69M | $259.69M |
FAQ
- What is Jazz Pharmaceuticals plc annual total long term liabilities?
- What is the all-time high annual long term liabilities for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc annual long term liabilities year-on-year change?
- What is Jazz Pharmaceuticals plc quarterly total long term liabilities?
- What is the all-time high quarterly long term liabilities for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc quarterly long term liabilities year-on-year change?
What is Jazz Pharmaceuticals plc annual total long term liabilities?
The current annual long term liabilities of JAZZ is $758.79M
What is the all-time high annual long term liabilities for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual total long term liabilities is $1.41B
What is Jazz Pharmaceuticals plc annual long term liabilities year-on-year change?
Over the past year, JAZZ annual total long term liabilities has changed by -$188.63M (-19.91%)
What is Jazz Pharmaceuticals plc quarterly total long term liabilities?
The current quarterly long term liabilities of JAZZ is $775.85M
What is the all-time high quarterly long term liabilities for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly total long term liabilities is $1.55B
What is Jazz Pharmaceuticals plc quarterly long term liabilities year-on-year change?
Over the past year, JAZZ quarterly total long term liabilities has changed by -$98.79M (-11.29%)